openPR Logo
Press release

Interventional Oncology - the future of Cancer Care, Leading players Boston Scientific, Varian Medical Systems, Merit Medical Systems, AtriCure, Inc., AngioDynamics, BTG plc, Siemens, Philips, GE Healthcare, Cook medical, Medtronic, Accuray, Nordion, and

03-26-2019 12:57 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Meticulous Research®

Interventional Oncology - the future of Cancer Care, Leading

Meticulous Research® – leading global market research company published a research report titled “Interventional Oncology Market by Procedure (Tumor ablation [Radiofrequency, Microwave], Radiotherapy [External, Internal, Systemic], Embolization, Proton Therapy), Application (Lung, Breast, Liver), and End user-Global Forecast to 2025”

Interventional oncology (IO) is an emerging field in cancer that extends the possibilities of existing treatment. It involves technique guided imaging systems such as computed tomography, fluoroscopy (live X-ray) or ultrasound to target solid tumors through a small skin puncture. Also, these techniques are often used with standard cancer treatments including surgery, chemotherapy, and radiation to reduce pain. This industry is witnessing a steady growth owing to growing preference for minimally invasive treatment procedures; increasing prevalence of chronic illness such as cancer; rising number of hospitals; and technological advancements in the field of radiology. Further, significant opportunities from emerging economies and introduction of cloud-based medical imaging have boosted the market growth. Moreover, the ongoing trend of integration of image-guided solutions with interventional oncology procedures is expected to boost the market growth in near future.

Download market research report @ https://www.meticulousresearch.com/download-sample-report/cp_id=4951

Increasing prevalence of cancer is propelling the global interventional oncology market

The growing aging population is leading to an increase in the prevalence of chronic diseases. According to United Nations, in 2017, population aged 60 years or over reached 962 million, which is expected to increase to 2.1 billion by 2050. Also, the number of persons aged 80 years or above is projected to increase threefold between 2017 and 2050, rising respectively from 137 million to 425 million.

According to WHO, cancer is the second leading cause of death globally, and was responsible for 9.8 million deaths worldwide in 2018. Among all types cancers, lung and breast cancer were the most common one with 2.09 million new cases, followed by colorectal (1.80 million cases), prostate (1.28 million cases), skin cancer (non-melanoma) (1.04 million cases), and stomach (1.03 million cases). Owing to high incidence & prevalence of cancer and high mortality associated with these diseases, the demand for interventional oncology procedures is rising globally.

Tumor ablation procedure to witness the largest demand through 2024

Tumor ablation commanded the largest share of the global interventional oncology market in 2018 due to minimal risk to patients, better penetration in tumors, and precise treatment capabilities in non-surgical candidates.

Lung cancer to dominate the interventional oncology market

Lung cancer commanded the largest share of the global interventional oncology market in 2018. The large share of this segment is attributed to large volume of new lung cancer cases reported each year, contributing significantly in the total burden of cancer incidences.

Hospitals to dominate the global interventional oncology market

Hospitals commanded the largest share of interventional oncology market in 2018. The factors such as growing healthcare expenditure across the globe, rising prevalence of oncology, growing awareness about the disease treatment, and higher preference for hospitals as suitable treatment location for the disease have led to the dominant share of hospitals in interventional oncology market.

Browse in-depth Report on https://www.meticulousresearch.com/product/interventional-oncology-market

Asia-Pacific: Fastest growing regional market

North America commanded the largest share of the global interventional oncology market in 2018, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa. However, Asia-Pacific will be the fastest growing regional market due to accelerated economic growth of many countries in this region and growing government focus on healthcare sector. In addition, government initiatives towards the development of healthcare facilities and increasing health insurance penetration are the key factors propelling the growth of the Asia-Pacific interventional oncology market.

The key players operating in the global interventional oncology market are Boston Scientific Corporation, Varian Medical Systems, Inc., Elekta AB, Merit Medical Systems, Inc., Profound Medical Corp., AtriCure, Inc., AngioDynamics, Inc., BTG plc, Terumo Corporation, Siemens AG, Koninklijke Philips N.V., GE Healthcare, Cook medical, Medtronic, PLC., Healthtronics, Inc., EdapTms S.A., Neuwave Medical, Inc., Accuray Incorporated, Ion Beam Applications, SA, Nordion Inc., C. R. Bard, Inc., Isoray Medical, Inc., and RaySearch Laboratories AB.

Download market research report @ https://www.meticulousresearch.com/download-sample-report/cp_id=4951

About Meticulous Research®

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

Contact us:
Khushal
Email: sales@meticulousresearch.com
Contact: +1-646-781-8004
Office No-202, 2nd Floor, Pushpak Business Hub, Wakad, Pune-411057

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Interventional Oncology - the future of Cancer Care, Leading players Boston Scientific, Varian Medical Systems, Merit Medical Systems, AtriCure, Inc., AngioDynamics, BTG plc, Siemens, Philips, GE Healthcare, Cook medical, Medtronic, Accuray, Nordion, and here

News-ID: 1672247 • Views:

More Releases from Meticulous Research®

Direct Air Capture Market: Transforming Carbon Removal for a Net-Zero Future
Direct Air Capture Market: Transforming Carbon Removal for a Net-Zero Future
Introduction The global Direct Air Capture (DAC) market has entered a period of rapid transformation as nations, industries, and corporations intensify their efforts to achieve net-zero emissions. Valued at $136.5 million in 2024, the market is projected to grow significantly, reaching approximately $6.93 billion by 2035. This expansion, driven by a remarkable compound annual growth rate (CAGR) of 43.3% between 2025 and 2035, highlights the growing importance of DAC technologies in
European Direct-to-Consumer Genetic Testing Market Outlook 2025-2035
European Direct-to-Consumer Genetic Testing Market Outlook 2025-2035
Introduction The European direct-to-consumer (DTC) genetic testing market is expanding at a remarkable pace, reflecting rising consumer interest in personalized healthcare and genetic insights. Valued at $464 million in 2025, the market is projected to grow at a compound annual growth rate (CAGR) of 23.3%, reaching nearly $3.78 billion by 2035. This growth underscores how advances in genomic sequencing, combined with increasing health awareness, are reshaping the healthcare and wellness landscape
Peer-to-Peer Energy Trading Platforms Market Outlook 2025-2035
Peer-to-Peer Energy Trading Platforms Market Outlook 2025-2035
Introduction The global peer-to-peer (P2P) energy trading platforms market is undergoing rapid transformation as new technologies reshape how energy is generated, distributed, and traded. Valued at $138 million in 2024, the market is projected to grow significantly, reaching nearly $2.34 billion by 2035. This growth, at a compound annual growth rate (CAGR) of 29.7% from 2025 to 2035, highlights the increasing adoption of decentralized energy solutions and digital platforms that empower
Dermoscopy and Skin Visualization Devices Market Outlook to 2035
Dermoscopy and Skin Visualization Devices Market Outlook to 2035
Introduction The global dermoscopy and skin visualization devices market is entering a phase of rapid transformation, driven by the increasing need for early detection of skin conditions and the rising incidence of skin cancer worldwide. Valued at $1.33 billion in 2024, the market is expected to reach nearly $3.3 billion by 2035, expanding from an estimated $1.43 billion in 2025 at a compound annual growth rate (CAGR) of 8.7% during the

All 5 Releases


More Releases for Interventional

Argon Medical's SuperCore Advantage In Interventional Oncology: The Driving Engi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Interventional Oncology Devices Market Through 2025? The market for interventional oncology devices has seen a robust expansion in recent times. Its growth trajectory forecasts a swell from $2.39 billion in 2024 to $2.52 billion in 2025, reflecting a compound annual growth rate
Neurovascular Devices/Interventional Neurology Market Poised for Growth Amid Adv …
The latest report "Neurovascular Devices/Interventional Neurology Market Share, Size, Growth, Opportunities, and Forecast 2024-2032" by Market Insights delivers a thorough analysis of the industry, encompassing market insights. It also covers competitor and regional analysis, along with recent advancements in the market. crucial factors boosting demand include a lesser focus on enhancing the seeker experience, managing large aspirant pools effectively, and using data analytics to optimize reclamation strategies. The report presents
Global Interventional Radiology Market Size & Trends
According to a new market research report published by Global Market Estimates, the global interventional radiology market is projected to grow at a CAGR of 5.4% from 2023 to 2028. The primary factors propelling the market growth are the increasing demand for minimally invasive procedures and the rising prevalence of chronic diseases such as heart disease, asthma, and others. Browse 147 Market Data Tables and 115 Figures spread through 163 Pages and
Interventional X-Ray Contrast Systems Market - Leading the way in high-quality i …
Newark, New Castle, USA: The "Interventional X-Ray Contrast Systems Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Interventional X-Ray Contrast Systems Market: https://www.growthplusreports.com/report/interventional-xray-contrast-systems-market/8613 This latest report researches the
Interventional Radiology Drainage Procedures Market - Advanced Interventional Ra …
Newark, New Castle, USA: The "Interventional Radiology Drainage Procedures Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Interventional Radiology Drainage Procedures Market: https://www.growthplusreports.com/report/interventional-radiology-drainage-procedures-market/8596 This latest report researches the
Interventional Oncology Market By Top Players -
Global Interventional Oncology Market Analysis According to Verified Market Research, the Global Interventional Oncology Market was valued at USD 1.78 Billion in 2018 and is projected to grow at a CAGR of 6.83% to reach USD 2.96 Billion by 2026, over the forecast period. What is Interventional Oncology? Interventional oncology deals with the diagnosis and treatment of cancer using minimally invasive procedures that are performed under image guidance. Interventional oncology is used to